The European Medicines Agency’s committee has recommended approval for a new formulation of Merck’s blockbuster cancer therapy Keytruda that can be administered under the…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/ema-committee-recommends-approval-injectable-version-mercks-2025a1000ozn?src=rss
Author :
Publish date : 2025-09-19 11:14:00
Copyright for syndicated content belongs to the linked Source.
